pe
pep-05391 v1 CC-BY-SA-4.0

CYCLOPS antiviral peptide

A short protein fragment studied for its ability to fight viruses; used only as a lab research tool.

statuscomputed targetANTIMICROBIAL length56 aa refs1
antiviral
EARLY ENTRY This candidate is newly indexed — supporting evidence is still being added. Have a paper or data point? Contribute below.
status 2 / 5 · 2 contributors
prediction metrics boltz-2 2.2.1
ipTM0.000
pTM0.854
avg pLDDT92.0
ranking score0.907
STRUCTURE · PEP-05391 × ANTIMICROBIAL
ranking0.907
?
RECEPTOR UNKNOWN
peptide conformation only · no target structure
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
sequence56 aa
151015202530354045505556
DKEWILQKIYEIMR LLDELGHAEASMRV SDLIYEFMKKGDER LLEEAERLLEEVER
in the news 6 articles
details expand to inspect
full evidence table1 metrics
metricvaluetool
ranking score 0.9069634675979614 boltz-2
3-letter notation
Asp-Lys-Glu-Trp-Ile-Leu-Gln-Lys-Ile-Tyr-Glu-Ile-Met-Arg-Leu-Leu-Asp-Glu-Leu-Gly-His-Ala-Glu-Ala-Ser-Met-Arg-Val-Ser-Asp-Leu-Ile-Tyr-Glu-Phe-Met-Lys-Lys-Gly-Asp-Glu-Arg-Leu-Leu-Glu-Glu-Ala-Glu-Arg-Leu-Leu-Glu-Glu-Val-Glu-Arg
recipeboltz-2 2.2.1
parametervalue
modelboltz-2 2.2.1
weights
hardwarevast_v100_32gb
mlx version
python
random seed1
msa strategynone_monomer
runtime
predicted by
predicted at2026-05-23
citationbibtex
peptidemodel (2026). CYCLOPS antiviral peptide (pep-05391, v1). PeptideModel. https://peptidemodel.com/card/pep-05391
@peptide{pep05391,
  sequence = {DKEWILQKIYEIMRLLDELGHAEASMRVSDLIYEFMKKGDERLLEEAERLLEEVER},
  target   = {antimicrobial},
  author   = {peptidemodel},
  year     = {2026},
  status   = {computed}
}
references 1 papers
[1]
De novo design of picomolar SARS-CoV-2 miniprotein inhibitors
Cao L; Goreshnik I; Coventry B; Case J; Miller L; Kozodoy L; Chen R; Carter L; Walls A; Park Y; Strauch E; Stewart L; Diamond M; Veesler D; Baker D Science 2020
source scaffold
discussion no comments
sign in to comment
peptidemodel.com CC-BY-SA-4.0 research only · not for human use